Comments
Loading...

Eagle Pharmaceuticals

EGRXOTCEM
Logo brought to you by Benzinga Data
$0.900000
0.2537.99%
At close: -

Eagle Pharmaceuticals (OTC:EGRX) Stock, Earnings Estimates, EPS, And Revenue

Eagle Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 8
EPS
Quarterly Revenue
Annual Revenue
(as of Jun 30)
$257.6M

Analyze the earnings history of Eagle Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Eagle Pharmaceuticals (EGRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20232023-08-08$1.18$1.0512.4 %
Mar 20232023-05-09$1.26$1.0520.0 %
Dec 20222023-03-13$1.10$0.8332.5 %
Sep 20222022-11-07$1.12$0.9123.1 %

Eagle Pharmaceuticals (EGRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20232023-08-08$64.65M$59.35M8.92 %
Mar 20232023-05-09$66.31M$63.29M4.76 %
Dec 20222023-03-13$60.70M$64.26M-5.54 %
Sep 20222022-11-07$65.90M$62.08M6.15 %

FAQ

Q

When is Eagle Pharmaceuticals (OTCEM:EGRX) reporting earnings?

A

Eagle Pharmaceuticals (EGRX) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Eagle Pharmaceuticals (OTCEM:EGRX)?

A

The Actual EPS was $0.00, which missed the estimate of $1.07.

Q

What were Eagle Pharmaceuticals’s (OTCEM:EGRX) revenues?

A

The Actual Revenue was $0K, which missed the estimate of $64.5M.

Browse earnings estimates, EPS, and revenue on all stocks.